Other Clinical Trial - Macular Function After Scleral Buckle

Status Completed

Clinical Trial Summary

Assess recovery of macula function after successful scleral buckling surgery for rhegmatogenous retinal detachment by using the multifocal ERG in the postoperative period i.e. recovery of functional integrity 2. Assess the relationship between the neurosensory retina and the retinal pigment epithelium/choriocapillaris after scleral buckling i.e. recovery of structural integrity 3. Assess if there is a difference between macula function postoperatively, in eyes with retinal detachments involving the macula and those that do not.

Clinical Trial Description

Patients with acute rhegmatogenous retinal detachments managed by scleral buckling surgery will be recruited into 3 groups. (Please see attached appendix A)

We define the area of the macula as the area within the temporal vascular arcades with the horizontal radius defined between the optic disc and the foveal centre.

Group A: Macula not detached Group B: Macula partially detached i.e. detachment stops within the macula Group C: Macula is totally detached

After scleral buckling surgery for the retinal detachment, the patients will be examined at Day 1, week 1, month1, 3 and 6. During these visits, they will be examined clinically, as well as undergo tests - refraction, colour vision (D-15) & contrast sensitivity testing, OCT and multifocal ERG. (Please see attaced visit schedule). ;

Study Design

Observational Model: Defined Population, Time Perspective: Longitudinal

Related Conditions & MeSH terms

Retinal Detachment
Rhegmatogenous Retinal Detachment

Clinical Trial Details

NCT number	NCT00345007
Study type	Observational
Source	Singapore National Eye Centre
Contact
Status	Completed
Phase	N/A
Start date	June 2005
Completion date	October 2006

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04403750` - Combined Laser-surgical Technology of RRD Treatment	N/A
Not yet recruiting	`NCT04520789` - Early Prevention Strategies of Severe Proliferative Vitreoretinopathy Base on Precision Diagnosis of Single Cell Sequencingvitreoretinopathy	N/A
Recruiting	`NCT04571788` - Treating Rhegmatogenous Retinal Detachment by Foldable Capsular Buckle
Completed	`NCT02834559` - Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.	Phase 3
Recruiting	`NCT01845571` - Retinal Detachment - Demographic and Clinical Survey
Completed	`NCT04891991` - Intravitreal Infliximab for Proliferative Vitreoretinopathy	Phase 2
Recruiting	`NCT02871531` - Pneumatic Retinopexy Versus Vitrectomy for Retinal Detachment in Patients With Extended Criteria	N/A
Completed	`NCT00757536` - Primary Vitrectomy With Endolaser or Encircling Band for Rhegmatogenous Retinal Detachment	N/A
Active, not recruiting	`NCT00370201` - Efficacy of Oral Colchicine in Prevention of Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment	Phase 3
Recruiting	`NCT05331664` - Dropless Pars Plana Vitrectomy Study	Phase 4
Completed	`NCT02841306` - Ursodeoxycholic Acid for Rhegmatogenous Retinal Detachment	Phase 1
Not yet recruiting	`NCT02185469` - Corneal Endothelial Cell Loss After Pneumatic Retinopexy for the Repair of Primary Rhegmatogenous Retinal Detachment	N/A
Not yet recruiting	`NCT01647373` - Axial Length Change in Eyes Treated by Silicone Sponge Scleral Buckling	N/A
Completed	`NCT01068379` - Clinical Trial of Cryotherapy Versus Postoperative Laser Photocoagulation	Phase 3
Recruiting	`NCT06056596` - Lamivudine and Plasma Markers of Inflammation in Retinal Detachment	Early Phase 1
Completed	`NCT01343134` - Anatomical and Functional Macular Changes in Retinal Detachment	N/A
Recruiting	`NCT05588037` - Combined Vitrectomy and Femtosecond Laser-assisted Cataract Surgery	N/A
Completed	`NCT03542162` - Healaflow Patch for the Treatment of Rhegmatogenous Retinal Detachment	N/A
Recruiting	`NCT05660447` - A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR	Phase 2/Phase 3
Not yet recruiting	`NCT06033703` - Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment	Phase 1/Phase 2